Literature DB >> 8962120

Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization.

S Tyagi1, K Bhol, K Natarajan, C Livir-Rallatos, C S Foster, A R Ahmed.   

Abstract

Ocular cicatricial pemphigoid (OCP) is an autoimmune disease that affects mainly conjunctiva and other squamous epithelia. OCP is histologically characterized by a separation of the epithelium from underlying tissues within the basement membrane zone. Immunopathological studies demonstrate the deposition of anti-basement membrane zone autoantibodies in vivo. Purified IgG from sera of patients with active OCP identified a cDNA clone from a human keratinocyte cDNA library that had complete homology with the cytoplasmic domain of beta 4-integrin. The sera recognized a 205-kDa protein in human epidermal, human conjunctiva, and tumor cell lysates that was identified as beta 4-integrin by its reaction with polyclonal and monoclonal antibodies to human beta 4-integrin. Sera from patients with bullous pemphigoid, pemphigus vulgaris, and cicatricial pemphigoid-like diseases did not recognize the 205-kDa protein, indicating the specificity of the binding. These data strongly implicate a role for human beta 4-integrin in the pathogenesis of OCP. It should be emphasized that multiple antigens in the basement membrane zone of squamous epithelia may serve as targets for a wide spectrum of autoantibodies observed in vesiculobullous diseases. Molecular definition of these autoantigens will facilitate the classification and characterization of subsets of cicatricial pemphigoid and help distinguishing them from bullous pemphigoid. This study highlights the function and importance of beta 4-integrin in maintaining the attachment of epithelial cells to the basement membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962120      PMCID: PMC26201          DOI: 10.1073/pnas.93.25.14714

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines.

Authors:  M E Hemler; C Crouse; A Sonnenberg
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

2.  Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources.

Authors:  T Hashimoto; M M Ogawa; A Konohana; T Nishikawa
Journal:  J Invest Dermatol       Date:  1990-03       Impact factor: 8.551

3.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Cicatricial pemphigoid.

Authors:  A R Ahmed; S M Hombal
Journal:  Int J Dermatol       Date:  1986-03       Impact factor: 2.736

6.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Immunoelectron microscopic findings in cicatricial pemphigoid: their significance in relation to epidermolysis bullosa acquisita.

Authors:  C Nieboer; D M Boorsma; M J Woerdeman
Journal:  Br J Dermatol       Date:  1982-04       Impact factor: 9.302

8.  Affinity purification of antibodies from diazotized paper blots of heterogeneous protein samples.

Authors:  J B Olmsted
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

9.  Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid.

Authors:  K Bhol; A Mohimen; R Neumann; J Yunis; S Foster; E J Yunis; A R Ahmed
Journal:  Curr Eye Res       Date:  1996-05       Impact factor: 2.424

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  19 in total

1.  [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

Authors:  I Elser; D Selimovic; T Ruzicka; A Kuhn; M Megahed
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

3.  Integrin: Basement membrane adhesion by corneal epithelial and endothelial cells.

Authors:  Tina B McKay; Ursula Schlötzer-Schrehardt; Sonali Pal-Ghosh; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2020-07-23       Impact factor: 3.467

4.  Comparison of reactivity and epitope recognition between sera from American and Italian patients with oral pemphigoid.

Authors:  M Mignogna; A Lanza; L Rossiello; V Ruocco; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 5.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

6.  Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.

Authors:  Akiko Imanishi; Hisayoshi Imanishi; Sho Hiroyasu; Toshiyuki Ozawa; Hiroshi Koga; Norito Ishii; Yasuo Kitajima; Takashi Hashimoto; Daisuke Tsuruta
Journal:  Med Mol Morphol       Date:  2015-12-10       Impact factor: 2.309

Review 7.  Mucous membrane pemphigoid.

Authors:  Hong-Hui Xu; Victoria P Werth; Ernesta Parisi; Thomas P Sollecito
Journal:  Dent Clin North Am       Date:  2013-08-15

8.  Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.

Authors:  N Sami; K C Bhol; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

9.  Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report.

Authors:  Joanna Dacosta
Journal:  Clin Ophthalmol       Date:  2012-12-14

10.  Treatment strategies in mucous membrane pemphigoid.

Authors:  Ann G Neff; Matthew Turner; Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.